A randomized controlled trial comparing efficacy and safety of insulin glargine 300 units/mL versus 100 units/mL in older people with type 2 diabetes: Results from the SENIOR study
Ritzel R et al. Diabetes Care 2018: dc180168. doi: 10.2337/dc18-0168
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.